当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第13期
编号:13052450
超声引导微波消融治疗T1a期肾癌的安全性评估(5)
http://www.100md.com 2017年5月5日 《中国医药导报》 2017年第13期
     [16] Ahmed M,Solbiati L,Brace CL,et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update [J]. Radiology,2014,273(1):241-260.

    [17] Dindo D,Demartines N,Clavien PA. Classification of surgical complications:a new proposal with evaluation in a cohort of 6336 patients and results of a survey [J]. Ann Surg,2004,240(2):205-213.

    [18] Atwell TD,Carter RE,Schmit GD,et al. Complications following 573 percutaneous renal radiofrequency and cryoablationprocedures [J]. J Vasc Interv Radiol,2012,23(1):48-54.

    [19] Atwell TD,Schmit GD,Boorjian SA,et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller:comparative local control and complications after radiofrequency ablation and cryoablation [J]. AJR Am J Roentgenol,2013,200(2):461-466.

    [20] Lee SJ,Choyke LT,Locklin JK,et al. Use of hydrodissection to prevent nerve and muscular damage during radiofrequency ablation of kidney tumors [J]. J VascInterv Radiol,2006, 17(12):1967-1969.

    [21] Boss A,Clasen S,Kuczyk M,et al. Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma:a potentially avoidable complication [J]. AJR Am J Roentgenol,2005,185(6):1627-1631.

    (收稿日期:2017-01-23 本文編辑:李岳泽), http://www.100md.com(程志刚 梁萍 于晓玲 韩治宇 刘方义 于杰 陈洪峰)
上一页1 2 3 4 5